| Literature DB >> 33562406 |
Rebecca Panconesi1, Mauricio Flores Carvalho1, Matteo Mueller2, David Meierhofer3, Philipp Dutkowski2, Paolo Muiesan1, Andrea Schlegel1,2.
Abstract
Based on the continuous increase of donor risk, with a majority of organs classified as marginal, quality assessment and prediction of liver function is of utmost importance. This is also caused by the notoriously lack of effective replacement of a failing liver by a device or intensive care treatment. While various parameters of liver function and injury are well-known from clinical practice, the majority of specific tests require prolonged diagnostic time and are more difficult to assess ex situ. In addition, viability assessment of procured organs needs time, because the development of the full picture of cellular injury and the initiation of repair processes depends on metabolic active tissue and reoxygenation with full blood over several hours or days. Measuring injury during cold storage preservation is therefore unlikely to predict the viability after transplantation. In contrast, dynamic organ preservation strategies offer a great opportunity to assess organs before implantation through analysis of recirculating perfusates, bile and perfused liver tissue. Accordingly, several parameters targeting hepatocyte or cholangiocyte function or metabolism have been recently suggested as potential viability tests before organ transplantation. We summarize here a current status of respective machine perfusion tests, and report their clinical relevance.Entities:
Keywords: liver transplantation; machine perfusion; mitochondria; viability testing
Year: 2021 PMID: 33562406 PMCID: PMC7915925 DOI: 10.3390/biomedicines9020161
Source DB: PubMed Journal: Biomedicines ISSN: 2227-9059